Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Growth Shares
3 top growth shares I would buy with $5,000
Healthcare Shares
3 quality healthcare shares I would buy today
Share Market News
How do I interpret a company's price-to-earnings (PE) ratio?
Bank Shares
Where to reinvest your National Australia Bank Ltd (ASX:NAB) dividends today
⏸️ Investing
Hospital stocks like Ramsay Health Care Limited (ASX:RHC) face a new risk in FY19
⏸️ Investing
ALL ORDINARIES (ASX:XAO) gains 9% in FY18
⏸️ Investing
ALL ORDINARIES finishes lower Friday: 8 shares you missed
⏸️ Investing
This could be the biggest risk to ResMed's (ASX:RMD) share price run in FY19
⏸️ Investing
Will Facebook launch a cryptocurrency bigger than bitcoin?
⏸️ Investing
Why I think RESMED (ASX:RMD) offers great value at this share price
⏸️ Investing
Why the Australian dollar is near a 52-week low & could slide further in 2019
⏸️ Investing
ALL ORDINARIES finishes lower Thursday: 8 shares you missed
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
